Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer

NCT00005023 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Ovarian Cancer

Interventions

BIOLOGICAL: HER-2/neu peptide vaccine
BIOLOGICAL: sargramostim

Sponsor

University of Washington